ZIG
GSK icon

Zullo Investment Group’s GSK GSK Stock Holding History

Zullo Investment Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,194
Closed -$42K – 377
2022
Q4 		$42K Sell
1,194
-140
-10% -$4.66K 0.03% 297
2022
Q3 		$39K Sell
1,334
-76
-5% -$2.88K 0.03% 302
2022
Q2 		$77K Buy
1,410
+248
+21% +$13.7K 0.05% 233
2022
Q1 		$63K Sell
1,162
-291
-20% -$15.8K 0.03% 274
2021
Q4 		$80K Buy
+1,453
New +$75.6K 0.04% 248

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zullo Investment Group's GSK Position: Q1 2023 in Review

Zullo Investment Group sold out of GSK (GSK) in Q1 2023, closing a stake of 1,194 shares — an estimated $42K sold.

Zullo Investment Group first reported a position in GSK in Q4 2021 and held it in 5 quarters. The position peaked at $80K in Q4 2021. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

  • Zullo Investment Group reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
  • Zullo Investment Group sold 1,194 GSK shares in Q1 2023, an estimated $42K.
  • Zullo Investment Group first reported a position in GSK in Q4 2021 and held it in 5 quarters.
  • Zullo Investment Group's GSK position peaked at $80K in Q4 2021.
  • 809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Zullo Investment Group's 13F filing for Q1 2023, filed 25 Apr 2023.